The Latest Breaking News from HIV

The U.K.’s National Institute for Health and Care Excellence (NICE) is recommending a treatment from a firm jointly owned by GSK Plc (NYSE:GSK), Pfizer Inc (NYSE:PFE) and Shionogi Inc.

The drug, known as cabotegravir, must be administered every two months.

The American South has the highest HIV rates in the country, accounting for more than half of new HIV diagnoses nationwide in 2023. This is despite growing availability of a highly effective HIV prevention medication that has made it possible to live a long, healthy life with this once fatal…

For the 2.3 million residents of Lesotho, the announcement of massive cuts to the U.S. aid that sustained much of the small African nation’s health care system came as a shock. The country long had one of the world’s highest HIV infection rates but recently made notable progress and hit…

In the wake of massive U.S. cuts to foreign aid, the tiny country of Lesotho in southern Africa faces deep uncertainty and worry over its HIV-positive residents

With the single stroke of Trump’s pen, much of a system credited with saving hundreds of thousands of lives was dismantled

South Africa's health minister has called lenacapavir, the first twice-yearly HIV prevention jab, a "groundbreaking" tool against the disease

The practice exposes others to bloodborne pathogens such as hepatitis and HIV.

Method has become popular among drug users in poverty-stricken areas of Africa and Pacific areas